| Financial Year |
March 31 2022 |
| Monetary Funds |
1,042,603,572.52 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
987,469,756.23 |
| Accounts Receivable |
1,472,956,826.36 |
| Advances to Suppliers |
77,860,262.16 |
| Other Receivables |
6,155,901.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
901,198,575.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
118,692,919.37 |
| Total Current Assets |
4,606,937,813.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,614,133.85 |
| Fixed Assetes |
1,472,990,032.43 |
| Under-construction Projects |
121,392,216.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
167,858,599.44 |
| R&D expenses |
-- |
| Goodwill |
185,289,590.07 |
| Long-Term Deferred and Prepaid Expenses |
1,527,911.40 |
| Deferred Income Tax Assets |
8,057,249.35 |
| Other Non-Current Assets |
10,349,095.63 |
| Sub-Total of Non-Current Assets |
1,970,078,828.82 |
| Total Assets |
6,577,016,642.30 |
| Short-Term Loans |
1,174,603,719.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,980,588,407.39 |
| Accounts Payable |
890,702,711.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,843,480.25 |
| Taxes Payable |
18,907,575.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
177,113,597.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
37,020,000.00 |
| Other Current Liabilities |
3,865,767.46 |
| Sub-Total of Current Liabilities |
4,333,800,531.78 |
| Long-term Loans |
125,560,281.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
285,444,842.32 |
| Total Liabilities |
4,619,245,374.10 |
| Paid-In Capital(Or Share Stock) |
511,320,000.00 |
| Capital Surplus |
576,868,858.74 |
| Surplus Reserve |
5,734,321.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
616,942,336.52 |
| Minority Stockholder's Interest |
245,628,730.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,712,142,537.50 |
| Owner's Equity（Stockholder's Equity） |
1,957,771,268.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,577,016,642.30 |
